Dairy and beef producers can now treat foot rot with convenient, single-dose anti-infectives – DRAXXIN (tulathromycin) Injectable Solution and EXCEDE (ceftiofur crystalline free acid) Sterile Suspension. In addition to treating bovine respiratory disease, DRAXXIN and EXCEDE are approved to effectively treat foot rot in cattle.

Foot rot is a common cause of cattle lameness that can affect just a few animals, or according to the “Beef Cattle Handbook,” 10 to 15% of a herd. And high intensity dairy operations have reported foot rot incidence rates up to 25%. Along with management techniques like clean and dry bedding and pens, foot rot management typically includes treating affected cattle with anti-infectives such as DRAXXIN or EXCEDE.

EXCEDE already provides broad-spectrum efficacy against BRD, and with its unique base of ear administration, now treats foot rot associated with Fusobacterium necrophorum and Porphyromonas levii. With the advantages of zero milk discard, EXCEDE’s extended therapy in a single dose delivers profitability to dairy producers with savings in time, labor and stress on dairy cows.

For dairy calves up to 20 months of age, DRAXXIN is the only anti-infective approved for the treatment of BRD caused by all four major pathogens, including Mycoplasma bovis, and pink eye. It now lends itself to greater efficiency options with its added label claim for the treatment of foot rot.

DRAXXIN is also the only anti-infective approved for the treatment and control of BRD, or calf pneumonia, in high-risk beef cattle. Working with a cattle’s immune system to treat disease without repeated administration, DRAXXIN is the only single-dose product available for BRD control and treatment associated with all four major pathogens, including Mycoplasma bovis, and now treats foot rot. DRAXXIN also treats pink eye associated with Moraxella bovis.

For beef cattle, EXCEDE provides extended therapy in a single-dose treatment for BRD and foot rot. Just a single dose of broad-spectrum EXCEDE works with the immune system of cattle without repeated administration to give an economically viable and effective treatment choice to producers.

DRAXXIN is not for use in female dairy cattle 20 months of age or older or in calves to be processed for veal. DRAXXIN has a pre-slaughter withdrawal time of 18 days.

As with all drugs, the use of EXCEDE Sterile Suspension is contraindicated in animals previously found to be hypersensitive to the drug. Though safe in cattle when properly administered, inadvertent intra-arterial injection in the ear is possible and is fatal. EXCEDE has a pre-slaughter withdrawal time of 13 days.